SELECTED IMPORTANT SAFETY INFORMATION
Some people who have taken medicine like ATRIPLA have developed
the following:

A serious condition called lactic acidosis (buildup of an acid in the
blood)

Serious liver problems called hepatotoxicity

A "flare-up" of hepatitis. If you have HIV-1 and hepatitis B virus (HBV) infection and you stop taking ATRIPLA, you may get a "flare-up" (a sudden worsening) of your hepatitis

Please click here for additional Important Safety Information, including Boxed WARNINGS.

ATRIPLA: in English | en español

Search:

How Does ATRIPLA Work?

ATRIPLA contains three HIV medicines in one pill: SUSTIVA^® (efavirenz), EMTRIVA^® (emtricitabine) and VIREAD^® (tenofovir disoproxil fumarate). This combination works to help lower the amount of HIV in the blood (called viral load) by interfering with the way HIV makes copies of itself (called viral replication). Lowering the amount of HIV in the blood may also help increase the number of T-cells (also called CD4+ cells). CD4+ cells are an important part of your immune system because they help the body fight infections.

For many patients, ATRIPLA may be a complete regimen, with three medicines from two different "classes," or types of drug, in one pill. For some patients, ATRIPLA may be taken with other medicines to treat HIV-1. ATRIPLA contains two NRTIs (emtricitabine and tenofovir disoproxil fumarate) and one NNRTI (efavirenz). Regimens that combine HIV medicines from different classes are effective because they help to slow HIV multiplication during several stages of the process.

ATRIPLA does not cure HIV-1 and has not been shown to prevent passing HIV-1 to others.

Ask your doctor if ATRIPLA is right for you, and see your healthcare provider regularly. Individual results may vary.

Please click here for Important Safety Information, including information on lactic acidosis, serious liver problems, and flare-ups of hepatitis B virus (HBV).

Please send me information and updates.

Find an HIV/AIDS Service Organization near you.

Distance to search:

Enter your ZIP code:

Site Map | Contact Us | Privacy Policy | Terms of Use | Unsubscribe

Click here for ATRIPLA Full Prescribing Information.

©2010 Bristol-Myers Squibb & Gilead Sciences, LLC. All rights reserved. ATRIPLA and ATRIPLA Peer Advocate Network are trademarks of Bristol-Myers Squibb & Gilead Sciences, LLC. EMTRIVA, TRUVADA, and VIREAD are trademarks of Gilead Sciences, Inc. SUSTIVA, REYATAZ, VIDEX, VIDEX EC, and Pravachol are registered trademarks of Bristol-Myers Squibb and its affiliated companies. All other trademarks are the property of their respective owners.

Patient models are used on this Web site. The information on this site is intended for residents of the United States who are 18 years of age or older. The content of this site is protected under applicable copyright and trademarks law.

This site may contain, from time to time, information related to various health, medical and fitness conditions, and their treatment. Such information is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult a physician and/or a healthcare provider.

Your use of this information is subject to the terms and conditions of our Terms of Use and Privacy Policy.

697US11WA07301 08/11